Growth Metrics

Evolent Health (EVH) Other financing activities (2016 - 2020)

Evolent Health has reported Other financing activities over the past 6 years, most recently at $33.7 million for Q1 2020.

  • For Q1 2020, Other financing activities rose 131.33% year-over-year to $33.7 million; the TTM value through Mar 2020 reached $36.9 million, up 425.28%, while the annual FY2019 figure was -$104.3 million, 208.44% down from the prior year.
  • Other financing activities for Q1 2020 was $33.7 million at Evolent Health, up from -$104.9 million in the prior quarter.
  • Over five years, Other financing activities peaked at $108.1 million in Q2 2019 and troughed at -$107.5 million in Q1 2019.
  • A 5-year average of $2.1 million and a median of $950000.0 in 2016 define the central range for Other financing activities.
  • Biggest five-year swings in Other financing activities: skyrocketed 2319.33% in 2018 and later crashed 209.07% in 2019.
  • Year by year, Other financing activities stood at $1.6 million in 2016, then surged by 1240.5% to $21.4 million in 2017, then surged by 348.31% to $96.2 million in 2018, then crashed by 209.07% to -$104.9 million in 2019, then soared by 132.11% to $33.7 million in 2020.
  • Business Quant data shows Other financing activities for EVH at $33.7 million in Q1 2020, -$104.9 million in Q4 2019, and -$1000.0 in Q3 2019.